Leukemia Drug for Parkinson's: A Second Look

]]>(MedPage Today) -- The chronic myeloid leukemia drug nilotinib (Tasigna) did not produce biological or clinically meaningful effects that would benefit people with Parkinson's disease, the NILO-PD trial suggested.Over 6 months, nilotinib had...